These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7475065)

  • 1. Argyrophilic nucleolar organizer region (AgNOR) area per nucleus as a prognostic factor in breast cancer.
    Nakayama K; Abe R
    J Surg Oncol; 1995 Nov; 60(3):160-7. PubMed ID: 7475065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status.
    Mourad WA; Erkman-Balis B; Livingston S; Shoukri M; Cox CE; Nicosia SV; Rowlands DT
    Cancer; 1992 Apr; 69(7):1739-44. PubMed ID: 1312892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
    Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
    Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma.
    Aubele M; Auer G; Jütting U; Falkmer U; Gais P
    Anal Quant Cytol Histol; 1994 Jun; 16(3):211-8. PubMed ID: 7522453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolus organizer regions (AgNORs) in ductal mammary carcinoma. Comparison with classifications and prognosis.
    Aubele M; Auer G; Gais P; Jütting U; Rodenacker K; Voss A
    Pathol Res Pract; 1994 Feb; 190(2):129-37. PubMed ID: 7520163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver-binding argyrophilic nucleolar organizer regions (AgNOR) in gall-bladder cancer: correlations with malignant grading and prognosis.
    Suzuki T; Takano Y; Kida Y; Okudaira M
    Acta Pathol Jpn; 1993; 43(1-2):36-43. PubMed ID: 8465655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
    Pich A; Chiarle R; Chiusa L; Palestro G
    Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argyrophilic nucleolar organizer regions in breast cancer: prognostic significance.
    Kolár Z; Zábranský T; Mattler K; Zábranský E
    Cesk Patol; 1992 Sep; 28(4):193-200. PubMed ID: 1335841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
    Gasińska A; Zabagło L; Cichocka A; Pudełek J; Urbański K; Skołyszewski J
    Folia Histochem Cytobiol; 1996; 34(2):95-101. PubMed ID: 8875218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of AgNORs in breast cancer].
    Aubele M; Auer G; Jütting U
    Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
    Babu M; Mathur M; Gupta SD; Chattopadhyay TK
    Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AgNORs in breast tumours.
    Ceccarelli C; Trerè D; Santini D; Taffurelli M; Chieco P; Derenzini M
    Micron; 2000 Apr; 31(2):143-9. PubMed ID: 10588060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
    Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
    Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argyrophilic nucleolar organizer regions: their value and correlation with clinical prognostic factors in breast carcinoma.
    Kumar A; Kushwaha AK; Kumar M; Gupta S
    J Surg Oncol; 1997 Jul; 65(3):201-4. PubMed ID: 9236930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
    Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
    Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
    Guski H; Hufnagl P; Kaufmann O; Krause M; Winzer KJ
    Anal Quant Cytol Histol; 2000 Jun; 22(3):206-12. PubMed ID: 10872036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of argyrophilic nucleolar organizer regions in nasopharyngeal carcinoma.
    Pak MW; To KF; Leung SF; van Hasselt CA
    Eur Arch Otorhinolaryngol; 2000 Nov; 257(9):517-20. PubMed ID: 11131381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear DNA content and nucleolar organizer regions in colorectal cancer.
    Adachi Y; Kido A; Mori M; Matsushima T; Shimono R; Inoue T; Sugimachi K
    J Surg Oncol; 1995 Jul; 59(3):177-80. PubMed ID: 7609524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argyrophilic nucleolar organizer regions in human adrenocortical neoplasms.
    Kida Y; Takano Y; Okudaira M
    J Cancer Res Clin Oncol; 1992; 119(1):49-54. PubMed ID: 1400566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.